Diabetes Care
Etki Faktörü - Analiz · Akım · Sıralama · Tahmin


Etki Faktörü




Etki Faktörü Trend

Related Journals

Popular Journals

Diabetes Care

The 2019-2020 Etki Faktörü of Diabetes Care is 16.019, which is just updated in 2020.

Diabetes Care Impact Factor
Highest IF
Highest Etki Faktörü

The highest Etki Faktörü of Diabetes Care is 16.019.

Lowest IF
Lowest Etki Faktörü

The lowest Etki Faktörü of Diabetes Care is 7.735.

Total Growth Rate
IF Total Growth Rate

The total growth rate of Diabetes Care IF is 98.1%.

Annual Growth Rate
IF Annual Growth Rate

The annual growth rate of Diabetes Care IF is 10.9%.

Etki Faktörü Ranking

Subcategory Quartile Rank Percentile
Endocrinology, Diabetes and Metabolism Q1 3/217

Endocrinology, Diabetes and Metabolism 98%

Advanced and Specialized Nursing Q1 1/59

Advanced and Specialized Nursing 99%

Internal Medicine Q1 2/128

Internal Medicine 98%

Etki Faktörü Ranking

· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of Diabetes Care is Q1. Diabetes Care has been ranked #3 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of Diabetes Care is around 98% in the field of Endocrinology, Diabetes and Metabolism.
· In the Advanced and Specialized Nursing research field, the Quartile of Diabetes Care is Q1. Diabetes Care has been ranked #1 over 59 related journals in the Advanced and Specialized Nursing research category. The ranking percentile of Diabetes Care is around 99% in the field of Advanced and Specialized Nursing.
· In the Internal Medicine research field, the Quartile of Diabetes Care is Q1. Diabetes Care has been ranked #2 over 128 related journals in the Internal Medicine research category. The ranking percentile of Diabetes Care is around 98% in the field of Internal Medicine.

Diabetes Care Impact Factor 2020-2021 Prediction

Diabetes Care Impact Factor Predition System

Diabetes Care Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions
Total Publications
Total Citations

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

Etki Faktörü History

Year Etki Faktörü
Year Etki Faktörü
2019-2020 16.019
2018-2019 15.27
2017-2018 13.397
2016-2017 11.857
2015-2016 8.934
2014-2015 8.42
2013-2014 8.57
2012-2013 7.735
2011-2012 8.087
Etki Faktörü History

· The 2019-2020 Etki Faktörü of Diabetes Care is 16.019
· The 2018-2019 Etki Faktörü of Diabetes Care is 15.27
· The 2017-2018 Etki Faktörü of Diabetes Care is 13.397
· The 2016-2017 Etki Faktörü of Diabetes Care is 11.857
· The 2015-2016 Etki Faktörü of Diabetes Care is 8.934
· The 2014-2015 Etki Faktörü of Diabetes Care is 8.42
· The 2013-2014 Etki Faktörü of Diabetes Care is 8.57
· The 2012-2013 Etki Faktörü of Diabetes Care is 7.735
· The 2011-2012 Etki Faktörü of Diabetes Care is 8.087

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
1977 0 5
1978 79 17
1979 97 101
1980 175 274
1981 153 498
1982 228 959
1983 174 1249
1984 164 1681
1985 175 2072
1986 173 2466
1987 196 2504
1988 210 3522
1989 161 3787
1990 253 3896
1991 213 4118
1992 319 5077
1993 376 5855
1994 317 6022
1995 319 6917
1996 354 7735
1997 468 9431
1998 564 11327
1999 534 13955
2000 465 18509
2001 491 23838
2002 534 29421
2003 785 39154
2004 726 45437
2005 677 55409
2006 727 65472
2007 854 78157
2008 661 85107
2009 672 88467
2010 695 98059
2011 671 105434
2012 558 117773
2013 866 125995
2014 636 135883
2015 491 129794
2016 441 117612
2017 397 109442
2018 405 91785
2019 421 96476
2020 585 112295
2021 71 7126
Publications Cites Dataset

· The Diabetes Care has published 0 reports and received 5 citations in 1977.
· The Diabetes Care has published 79 reports and received 17 citations in 1978.
· The Diabetes Care has published 97 reports and received 101 citations in 1979.
· The Diabetes Care has published 175 reports and received 274 citations in 1980.
· The Diabetes Care has published 153 reports and received 498 citations in 1981.
· The Diabetes Care has published 228 reports and received 959 citations in 1982.
· The Diabetes Care has published 174 reports and received 1249 citations in 1983.
· The Diabetes Care has published 164 reports and received 1681 citations in 1984.
· The Diabetes Care has published 175 reports and received 2072 citations in 1985.
· The Diabetes Care has published 173 reports and received 2466 citations in 1986.
· The Diabetes Care has published 196 reports and received 2504 citations in 1987.
· The Diabetes Care has published 210 reports and received 3522 citations in 1988.
· The Diabetes Care has published 161 reports and received 3787 citations in 1989.
· The Diabetes Care has published 253 reports and received 3896 citations in 1990.
· The Diabetes Care has published 213 reports and received 4118 citations in 1991.
· The Diabetes Care has published 319 reports and received 5077 citations in 1992.
· The Diabetes Care has published 376 reports and received 5855 citations in 1993.
· The Diabetes Care has published 317 reports and received 6022 citations in 1994.
· The Diabetes Care has published 319 reports and received 6917 citations in 1995.
· The Diabetes Care has published 354 reports and received 7735 citations in 1996.
· The Diabetes Care has published 468 reports and received 9431 citations in 1997.
· The Diabetes Care has published 564 reports and received 11327 citations in 1998.
· The Diabetes Care has published 534 reports and received 13955 citations in 1999.
· The Diabetes Care has published 465 reports and received 18509 citations in 2000.
· The Diabetes Care has published 491 reports and received 23838 citations in 2001.
· The Diabetes Care has published 534 reports and received 29421 citations in 2002.
· The Diabetes Care has published 785 reports and received 39154 citations in 2003.
· The Diabetes Care has published 726 reports and received 45437 citations in 2004.
· The Diabetes Care has published 677 reports and received 55409 citations in 2005.
· The Diabetes Care has published 727 reports and received 65472 citations in 2006.
· The Diabetes Care has published 854 reports and received 78157 citations in 2007.
· The Diabetes Care has published 661 reports and received 85107 citations in 2008.
· The Diabetes Care has published 672 reports and received 88467 citations in 2009.
· The Diabetes Care has published 695 reports and received 98059 citations in 2010.
· The Diabetes Care has published 671 reports and received 105434 citations in 2011.
· The Diabetes Care has published 558 reports and received 117773 citations in 2012.
· The Diabetes Care has published 866 reports and received 125995 citations in 2013.
· The Diabetes Care has published 636 reports and received 135883 citations in 2014.
· The Diabetes Care has published 491 reports and received 129794 citations in 2015.
· The Diabetes Care has published 441 reports and received 117612 citations in 2016.
· The Diabetes Care has published 397 reports and received 109442 citations in 2017.
· The Diabetes Care has published 405 reports and received 91785 citations in 2018.
· The Diabetes Care has published 421 reports and received 96476 citations in 2019.
· The Diabetes Care has published 585 reports and received 112295 citations in 2020.
· The Diabetes Care has published 71 reports and received 7126 citations in 2021.
· The total publications of Diabetes Care is 18532.
· The total citations of Diabetes Care is 1870113.

Diabetes Care
Journal Profile
Diabetes Care | Academic Accelerator - About the Journal


Diabetes Care is a journal for the health care practitioner that is intended to increase knowledge, stimulate research, and promote better management of people with diabetes. To achieve these goals, the journal publishes original research on human studies in the following categories: Clinical Care/Education/Nutrition/Psychosocial Research, Epidemiology/Health Services Research,Emerging Treatments and Technologies, Pathophysiology/Complications, and Cardiovascular and Metabolic Risk. The journal also publishes ADA statements, consensus reports, clinically relevant review articles, letters to the editor, and health/medical news or points of view. Topics covered are of interest to clinically oriented physicians, researchers, epidemiologists, psychologists, diabetes educators, and other health professionals. Diabetes Care is a monthly peer-reviewed medical journal published since 1978 by the American Diabetes Association. The journal covers research in the following five categories: 1) clinical care/education/nutrition/psychosocial research, 2) epidemiology/health services research, 3) emerging treatments and technologies, 4) pathophysiology/complications, and 5) cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries.


The ISSN of Diabetes Care is 1935-5548 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
ISSN (Online)

The ISSN (Online) of Diabetes Care is 0149-5992 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

American Diabetes Association Inc.

Diabetes Care is published by American Diabetes Association Inc. .

Publication Frequency
Publication Frequency

Diabetes Care publishes reports Monthly .

1978 - Present

The Publication History of Diabetes Care covers 1978 - Present .

Open Access
Open Access

Diabetes Care is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Publication Fee

There is no publication fee for submiting manuscript to Diabetes Care. Diabetes Care is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.


The language of Diabetes Care is English .

United States

The publisher of Diabetes Care is American Diabetes Association Inc. , which locates in United States .

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

Diabetes Care | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The Diabetes Care Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Diabetes Care during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Diabetes Care.


The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor


  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.


Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)

Selected Articles

Full Title Authors
Full Title Authors
Area Deprivation and Regional Disparities in Treatment and Outcome Quality of 29,284 Pediatric Patients With Type 1 Diabetes in Germany: A Cross-sectional Multicenter DPV Analysis Jing W. Hughes · Yicheng K. Bao · Yicheng K. Bao · Maamoun Salam · Prajesh Joshi · Prajesh Joshi · C. Rachel Kilpatrick · Kavita Juneja · David Nieves · David Nieves · Victoria Bouhairie · Victoria Bouhairie · Olivia J. Jordan · Olivia J. Jordan · Erica C. Blustein · Erica C. Blustein · Garry S. Tobin · Janet B. McGill
Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults N. Wah Cheung · N. Wah Cheung · Robert G. Moses
Big Topics for Diabetes Care in 2018: Clinical Guidelines, Costs of Diabetes, and Information Technology Thomas Danne · Bertrand Cariou · Phillip Banks · Michael Brändle · Helmut Brath · Edward Franek · Jake A. Kushner · Pablo Lapuerta · Darren K. McGuire · Anne L. Peters · Sangeeta Sawhney · Paul Strumph
Long-term Outcomes of Lifestyle Intervention to Prevent Diabetes in American Indian and Alaska Native Communities: The Special Diabetes Program for Indians Diabetes Prevention Program Tina Costacou · Jamie L. Crandell · Anna R. Kahkoska · Angela D. Liese · Dana Dabelea · Jean M. Lawrence · David J Pettitt · Kristi Reynolds · Elizabeth J. Mayer-Davis · Amy K. Mottl
Ambulatory Medication Reconciliation and Frequency of Hospitalizations and Emergency Department Visits in Patients With Diabetes David C. Klonoff · Joan Lee Parkes · Boris P. Kovatchev · David Kerr · Wendy C. Bevier · Ronald L. Brazg · Mark P. Christiansen · Timothy S. Bailey · James H. Nichols · Michael A. Kohn
Social Network Characteristics Are Associated With Type 2 Diabetes Complications: The Maastricht Study Sven Kohler · Stefan Kaspers · Afshin Salsali · Cordula Zeller · Hans J. Woerle
Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes Nils Swindell · Kelly A. Mackintosh · Melitta A. McNarry · Jeffrey W. Stephens · Diewertje Sluik · Mikael Fogelholm · Mathijs Drummen · Ian A. Macdonald · J. Alfredo Martínez · Teodora Handjieva-Darlenska · Sally D. Poppitt · Jennie Brand-Miller · Thomas Meinert Larsen · Anne Raben · Gareth Stratton
Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes Nathaniel L. Baker · Kelly J. Hunt · Danielle R. Stevens · Gabor Jarai · Glenn D. Rosen · Richard L. Klein · Gabriel Virella · Maria F. Lopes-Virella
The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes Xiaoquan Rao · Jeffrey A. Deiuliis · Georgeta Mihai · Juliet Varghese · Chang Xia · Matthew B. Frieman · Carole Sztalryd · Xiao Jian Sun · Michael J. Quon · Simeon I Taylor · Sanjay Rajagopalan · Jixin Zhong
Severity of Neuropathy Is Associated With Long-term Spinal Cord Stimulation Outcome in Painful Diabetic Peripheral Neuropathy: Five-Year Follow-up of a Prospective Two-Center Clinical Trial B. Bauduceau · Jean-Pierre Le Floch · Serge Halimi · C. Verny · J. Doucet · Sfgg Intergroup
Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional Comparison Nilka Ríos Burrows · Yanfeng Li · Edward W. Gregg · Linda S. Geiss
Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes Manan Pareek · Manan Pareek · Deepak L. Bhatt · Mette Lundgren Nielsen · Ram Jagannathan · Karl-Fredrik Eriksson · Peter Nilsson · Michael Bergman · Michael H. Olsen
Monocyte DPP4 Expression in Human Atherosclerosis Is Associated With Obesity and Dyslipidemia Melinda E. Chen · Aaditya G. Chandramouli · Robert V. Considine · Tamara S. Hannon · Kieren J. Mather
Cardiovascular Complications Over 5 Years and Their Association With Survival in the GERODIAB Cohort of Elderly French Patients With Type 2 Diabetes Basilio Pintaudi · Giacoma Di Vieste
Enhanced predictive capability of a 1-hour oral glucose tolerance test : A prospective population-based cohort study Daniel Ruiz · Marisol Becerra · Jyotsna S. Jagai · Kerry Ard · Robert M. Sargis
The role of diabetes care and its contributions to the field of diabetes: A profile in progress Seth A. Berkowitz · Andrew J. Karter · Giselle Corbie-Smith · Hilary K. Seligman · Hilary K. Seligman · Sarah A. Ackroyd · Lily S. Barnard · Steven J. Atlas · Deborah J. Wexler
A1C targets should be personalized to maximize benefits while limiting risks J Dennis · William Henley · Michael N. Weedon · Mike Lonergan · L Rodgers · Angus G. Jones · Angus G. Jones · William Hamilton · Naveed Sattar · Salim Janmohamed · R R Holman · R R Holman · Ewan R. Pearson · Beverley M. Shields · Andrew T. Hattersley · Andrew T. Hattersley
Comment on Ooi and Wong. Twin Pregnancy With Gestational Diabetes Mellitus: A Double Whammy? Diabetes Care 2018;41:e15–e16 Jianguang Ji · Tianhui Chen · Jan Sundquist · Jan Sundquist · Kristina Sundquist · Kristina Sundquist
Effect of High-Deductible Insurance on High-Acuity Outcomes in Diabetes: A Natural Experiment for Translation in Diabetes (NEXT-D) Study Aaron A. Lee · John D. Piette · Michele Heisler · Ann-Marie Rosland
Comment on Santema et al. Hyperbaric Oxygen Therapy in the Treatment of Ischemic Lower-Extremity Ulcers in Patients With Diabetes: Results of the DAMO2CLES Multicenter Randomized Clinical Trial. Diabetes Care 2018;41:112–119 Magnus F. Grøndahl · Jonatan I. Bagger · Asger Lund · Annesofie Faurschou · Jens F. Rehfeld · Jens J. Holst · Tina Vilsbøll · Filip K. Knop
Gestational Diabetes Mellitus: Does One Size Fit All? A Challenge to Uniform Worldwide Diagnostic Thresholds Mesut Mutluoğlu
Response to comment on Lent et al. All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes. Diabetes Care 2017;40:1379–1385 Matthew C. Riddle · Michael I. Miller
Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943–950. Comment on Bowering et al. Diabetes Care 2017;40:951–957 Elizabeth A. Pyatak · Kristine Carandang · Cheryl Vigen · Jeanine Blanchard · Jesus Diaz · Alyssa Concha-Chavez · Paola A. Sequeira · Jamie R. Wood · Robin Whittemore · Donna Spruijt-Metz · Anne L. Peters
Prevalence and Prognostic Impact of Diabetes in Takotsubo Syndrome: Insights From the International, Multicenter GEIST Registry Lucien Marchand · Arnaud Thivolet · Pierre Saintigny · Nicole Fabien · Julien Vouillarmet · Charles Thivolet
Response to Comment on Edelman and Polonsky. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 2017;40:1425–1432 Donald C. Simonson · Florencia Halperin · Kathleen Foster · Ashley H. Vernon · Allison B. Goldfine
Comment on Ohkuma et al. Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial. Diabetes Care 2017;40:1203–1209 Esmeralda Castelblanco · Marta Hernández · Andrea Castelblanco · Mònica Gratacòs · Aureli Esquerda · Angels Mollo · Anna Ramírez-Morros · Jordi Real · Josep Franch-Nadal · José-Manuel Fernández-Real · Didac Mauricio
Scientific Exploration With Continuous Monitoring Systems: An Early Assessment of Arrhythmias During Hypoglycemia Sarah Stark Casagrande · Laura N. McEwen · William H. Herman
Occupational Therapy Intervention Improves Glycemic Control and Quality of Life Among Young Adults With Diabetes: the Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) Randomized Controlled Trial Michael J. Campbell · Simon Heller · Richard Jacques
Decreasing an Offloading Devices Size and Offsetting Its Imposed Limb-Length Discrepancy Lead to Improved Comfort and Gait Rebecca E. Graff · Rebecca E. Graff · Alejandro Sanchez · Deirdre K. Tobias · Deirdre K. Tobias · Dayron Rodriguez · Glen W. Barrisford · Michael L. Blute · Yanping Li · Qi Sun · Qi Sun · Mark A. Preston · Kathryn M. Wilson · Kathryn M. Wilson · Eunyoung Cho · Eunyoung Cho
Using Indirect Measures to Identify Geographic Hot Spots of Poor Glycemic Control: Cross-sectional Comparisons With an A1C Registry Samantha A. Barry · David M. Harlan · Nicole L. Johnson · Kristin L. MacGregor
Hemoglobin A1c Accurately Predicts Continuous Glucose Monitoring–Derived Average Glucose in Youth and Young Adults With Cystic Fibrosis David Beran · Irl B. Hirsch · John S. Yudkin
Metabolic Syndrome and Neurocognition Among Diverse Middle-Aged and Older Hispanics/Latinos: HCHS/SOL Results Julio A. Lamprea‐Montealegre · Ian H. de Boer
Gaps in Guidelines for the Management of Diabetes in Low- and Middle-Income Versus High-Income Countries—A Systematic Review Clare B. Kelly · Clare B. Kelly · Michelle B. Hookham · Jeremy Y. Yu · Jeremy Y. Yu · Alicia J. Jenkins · Alicia J. Jenkins · Alison Nankervis · Kristian F. Hanssen · Kristian F. Hanssen · Satish K. Garg · James A. Scardo · Samar M. Hammad · M. Kathryn Menard · Christopher E. Aston · Timothy J. Lyons · Timothy J. Lyons
Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies Michael R. Rickels · Stephanie N. DuBose · Elena Toschi · Roy W. Beck · Alandra S. Verdejo · Howard Wolpert · Martin J. Cummins · Brett Newswanger · Michael C. Riddell
State of Behavioral Health Integration in U.S. Diabetes Care: How Close Are We to ADA Recommendations? Dimpi Desai · Dhruv Mehta · Priyanka Mathias · Gopal Menon · Ulrich K. Schubart
Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes Samy Suissa
Response to Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120–127 Margaret M. McCarthy · Margaret Grey
Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes Matthew C. Riddle · Hertzel C. Gerstein · R R Holman · Silvio E. Inzucchi · Bernard Zinman · Sophia Zoungas · William T. Cefalu
Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis Ronald T. Ackermann
Response to Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6–10 Joao Sergio Neves · Miguel Bigotte Vieira · Lia Leitão · Catarina Dias · Rita Magriço · Ana Isabel Oliveira · Davide Carvalho
Erratum. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care 2016;39:808–815 Matthew C. Riddle · William H. Herman
Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes Jasmin Divers · Barry I. Freedman
Elevated Hemoglobin A1c Is Associated With Incident Diabetes Within 4 Years Among Normoglycemic, Working-Age Individuals in an Employee Wellness Program Beverley M. Shields · Timothy J. McDonald · Richard A. Oram · Anita Hill · Michelle Hudson · Pia Leete · Ewan R. Pearson · Sarah J. Richardson · Noel G. Morgan · Andrew T. Hattersley
Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial Anna Vittoria Mattioli · Francesca Coppi · Alberto Farinetti
Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors Teryl K. Nuckols · Teryl K. Nuckols · Emmett B. Keeler · Laura Anderson · Laura Anderson · Jonas B. Green · Sally C Morton · Brian Doyle · Kanaka D Shetty · Aziza Arifkhanova · Marika Booth · Roberta Shanman · Paul G. Shekelle
Diabetes-Attributable Nursing Home Costs for Each U.S. State Betiel K. Fesseha · Christopher J. Abularrage · Kathryn F. Hines · Ronald L. Sherman · Priscilla Frost · Susan Langan · Joseph K. Canner · Kendall Likes · Sayed Mohammad Hosseini · Gwendolyne Jack · Caitlin W. Hicks · Swaytha Yalamanchi · Nestoras Mathioudakis
Gestational Diabetes Mellitus and Renal Function: A Prospective Study With 9- to 16-Year Follow-up After Pregnancy Lois Jovanovic
Economic Evaluation of Quality Improvement Interventions Designed to Improve Glycemic Control in Diabetes: A Systematic Review and Weighted Regression Analysis Yanping Li · Frank B. Hu · Frank B. Hu
Lifetime Prevalence and Prognosis of Prediabetes Without Progression to Diabetes Francesca Santilli · Paola Simeone · Guagnano Mt · Marika Leo · Marica Tina Maccarone · Augusto Di Castelnuovo · Cristina Sborgia · Riccardo C. Bonadonna · Ermanno Angelucci · Virginia Federico · Stefano Cianfarani · Stefano Cianfarani · Lamberto Manzoli · Giovanni Davì · Armando Tartaro · Agostino Consoli
Association of Hemoglobin A1c and Wound Healing in Diabetic Foot Ulcers Leonard Pogach · David C. Aron
Comment on Pareek et al. Enhanced Predictive Capability of a 1-Hour Oral Glucose Tolerance Test: A Prospective Population-Based Cohort Study. Diabetes Care 2018;41:171–177 Zachary T. Bloomgarden · Daniel Einhorn · Daniel Einhorn · Yehuda Handelsman
Response to Comment on Li et al. Time Trends of Dietary and Lifestyle Factors and Their Potential Impact on Diabetes Burden in China. Diabetes Care 2017;40:1685–1694 Ying Zheng · Zhen Wang
Are We There Yet? Finding Ways to Work Together on T1D Michelle R. Lent · Peter N. Benotti · G. Craig Wood
Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998–2013: A Retrospective Cohort Study Tingting Geng · Caren E. Smith · Changwei Li · Tao Huang · Tao Huang
Response to Comment on Ohkuma et al. Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial. Diabetes Care 2017;40:1203–1209 Samy Suissa
Comment on Chan et al. FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes. Diabetes Care 2018;41:178–186 Dov Shiffman · Carmen H. Tong · Charles M. Rowland · James J. Devlin · James B. Meigs · Michael J. McPhaul
Gestational Diabetes Mellitus and Diet: A Systematic Review and Meta-analysis of Randomized Controlled Trials Examining the Impact of Modified Dietary Interventions on Maternal Glucose Control and Neonatal Birth Weight Pichamol Jirapinyo · Pichamol Jirapinyo · Andrea V. Haas · Andrea V. Haas · Christopher C. Thompson · Christopher C. Thompson
Insulin Access and Affordability Working Group: Conclusions and Recommendations Sarah Steven · Kieren G. Hollingsworth · Ahmad Al-Mrabeh · Leah Avery · Benjamin S. Aribisala · Muriel J. Caslake · Roy Taylor
Cost-effectiveness of a New Opportunistic Screening Strategy for Walk-in Fingertip HbA1c Testing at Community Pharmacies in Japan Andrew D. Calvin · Niti R. Aggarwal · Mohammad Hassan Murad · Qian Shi · Mohamed B. Elamin · Jeffrey B. Geske · M. Mercè Fernández-Balsells · Felipe N. Albuquerque · Julianna F. Lampropulos · Patricia J. Erwin · Steven A. Smith · Victor M. Montori
Disparities in Environmental Exposures to Endocrine-Disrupting Chemicals and Diabetes Risk in Vulnerable Populations Gina Agiostratidou · Henry Anhalt · Dana Ball · Lawrence Blonde · Evgenia Gourgari · Karen N. Harriman · Aaron J. Kowalski · Paul Madden · Alicia H. McAuliffe-Fogarty · Molly McElwee-Malloy · Anne Peters · Sripriya Raman · Kent Reifschneider · Karen Rubin · Stuart A. Weinzimer
Physical Activity in Patients With Type 2 Diabetes: The Case for Objective Measurement in Routine Clinical Care Andres DiGenio · Nguyen C. Pham · Lynnetta Watts · Erin S. Morgan · Shiangtung W. Jung · Brenda F. Baker · Richard S. Geary · Sanjay Bhanot
LDL Cholesterol Rises With BMI Only in Lean Individuals: Cross-Sectional U.S. and Spanish Representative Data Qianrui Li · Qianrui Li · Yuling Xiao · Anoop Dinesh Shah · Anoop Dinesh Shah · Sheyu Li · Sheyu Li
PedsQL 3.2 Diabetes Module for Children, Adolescents, and Young Adults: Reliability and Validity in Type 1 Diabetes Angela C. Shore · Helen M. Colhoun · Andrea Natali · Carlo Palombo · Faisel Khan · Gerd Östling · Kunihiko Aizawa · Cecilia Kennbäck · Francesco Casanova · Margaretha Persson · Kim Gooding · Phillip E. Gates · Helen C. Looker · Fiona Dove · J. J. F. Belch · Silvia Pinnola · Elena Venturi · Michaela Kozakova · Isabel Gonçalves · Jasmina Kravic · Harry Björkbacka · Jan Nilsson
Lifestyle Intervention in Danish Obese Pregnant Women With Early Gestational Diabetes Mellitus According to WHO 2013 Criteria Does Not Change Pregnancy Outcomes: Results From the LiP (Lifestyle in Pregnancy) Study Chantal Mathieu · Paresh Dandona · Pieter Gillard · Peter A. Senior · Christoph Hasslacher · Eiichi Araki · Marcus Lind · Stephen C. Bain · Serge Jabbour · Niki Arya · Lars Hansen · Fredrik Thorén · Anna Maria Langkilde
The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial Ildiko Lingvay · Cyrus V. Desouza · Katarina Lalic · Ludger Rose · Thomas Kruse Hansen · Jeppe Zacho · Thomas R. Pieber
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes Rachel T. McGrath · Sarah J. Glastras · Samantha L. Hocking · Gregory R. Fulcher
Primum Non Nocere: Refocusing Our Attention on Severe Hypoglycemia Prevention Ming-Shan He · Fang-Ling Chang · Hong-Zin Lin · Jung-Lun Wu · Tsung-Cheng Hsieh · Yuan-Chieh Lee
Visual Inspection of Chromatograms Assists Interpretation of HbA1c: A Case Report Michaël J.B. van Baar · Charlotte C. van Ruiten · Marcel H.A. Muskiet · Liselotte van Bloemendaal · Richard G. IJzerman · Daniël H. van Raalte
The Association Between Diabetes and Age-Related Macular Degeneration Among the Elderly in Taiwan Julia Critchley · Iain M. Carey · Tess Harris · Stephen DeWilde · Fay J. Hosking
SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management Jane L. Chiang · David M. Maahs · Katharine C. Garvey · Korey K. Hood · Lori Laffel · Stuart A. Weinzimer · Joseph I. Wolfsdorf · Desmond A. Schatz
The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (the Diabetes & Aging Study) Hunter Wessells · Barbara H. Braffett · Sarah K. Holt · Alan M. Jacobson · John W. Kusek · Catherine C. Cowie · Rodney L. Dunn · Aruna V. Sarma
Trajectory of Disability in Older Adults With Newly Diagnosed Diabetes: Role of Elevated Depressive Symptoms Gregory P. Forlenza · Zoey Li · Bruce Buckingham · Jordan E. Pinsker · Eda Cengiz · R. Paul Wadwa · Laya Ekhlaspour · Mei Mei Church · Stuart A. Weinzimer · Emily Jost · Tatiana Marcal · Camille C. Andre · Lori Carria · Vance Swanson · John Lum · Craig Kollman · William Woodall · Roy W. Beck
Erratum. Mediterranean Diet, Retinopathy, Nephropathy, and Microvascular Diabetes Complications: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2015;38:2134–2141 Tianyi Huang · Tianyi Huang · Brian M. Lin · Brian M. Lin · Meir J. Stampfer · Meir J. Stampfer · Shelley S. Tworoger · Frank B. Hu · Frank B. Hu · Susan Redline · Susan Redline
Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association Miranda M. Broadney · Britni R. Belcher · David Berrigan · Robert J. Brychta · Ira L. Tigner · Faizah Shareef · Alexia Papachristopoulou · Jacob D. Hattenbach · Elisabeth K. Davis · Sheila M. Brady · Shanna Bernstein · Amber B. Courville · Bart E. Drinkard · Kevin P. Smith · Douglas R. Rosing · Pamela L. Wolters · Kong Y. Chen · Jack A. Yanovski
Exercise Response Variations in Skeletal Muscle PCr Recovery Rate and Insulin Sensitivity Relate to Muscle Epigenomic Profiles in Individuals With Type 2 Diabetes Jin Zhou · Dawn C. Schwenke · Gideon D. Bahn
Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial Yu-Feng Lin · Shuei-Liong Lin · Tao-Min Huang · Shao-Yu Yang · Tai-Shuan Lai · Likwang Chen · Vin-Cent Wu · Tzong-Shinn Chu · Kwan-Dun Wu
A Population-Based Study of the Bidirectional Association Between Obstructive Sleep Apnea and Type 2 Diabetes in Three Prospective U.S. Cohorts Jordi Salas-Salvadó · Mònica Bulló · Nancy Babio · Miguel Ángel Martínez-González · Núria Ibarrola-Jurado · Josep Basora · Ramón Estruch · Maria Isabel Covas · Dolores Corella · Fernando Arós · Valentina Ruiz-Gutiérrez · Emilio Ros
Associations Between Oral Health Status and Diabetic Neuropathy in a Large Romanian Cohort of Patients With Diabetes Serge Jabbour · Juan P. Frias · Elise Hardy · Azazuddin Ahmed · Hui Wang · Peter Öhman · Cristian Guja
Effects of Interrupting Sedentary Behavior With Short Bouts of Moderate Physical Activity on Glucose Tolerance in Children With Overweight and Obesity: A Randomized, Crossover Trial Patrick G. Gavin · Jane A. Mullaney · Dorothy Loo · Kim-Anh Lê Cao · Peter A. Gottlieb · Michelle M. Hill · Danny Zipris · Emma E. Hamilton-Williams
Success in Achieving the Targets of the 20-Year Infancy-Onset Dietary Intervention: Association With Insulin Sensitivity and Serum Lipids Julio Rosenstock · Alice Cheng · Robert Ritzel · Zsolt Bosnyak · Christine Devisme · Anna M.G. Cali · Jochen Sieber · Peter Stella · Xiangling Wang · Juan P. Frias · Ronan Roussel · Ronan Roussel · Geremia B. Bolli
New-Onset Diabetes After Acute Kidney Injury Requiring Dialysis Sonya S. Deschênes · Sonya S. Deschênes · Eva Graham · Eva Graham · Mika Kivimäki · Norbert Schmitz · Norbert Schmitz
Erratum. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 2011;34:14–19 Lasse Bjerg · Lasse Bjerg · Adam Hulman · Bendix Carstensen · Morten Charles · Marit E. Jørgensen · Marit E. Jørgensen · Daniel R. Witte
Renal and Cardiovascular Risk According to Tertiles of Urinary Albumin-to-Creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT) Anna R. Kahkoska · John B. Buse
Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial Fernando Bril · Kenneth Cusi
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial Cynthia A. Berg · Deborah J. Wiebe · Deborah J. Wiebe · Yana Suchy · Sara L. Turner · Jonathan Butner · Ascher Munion · Amy Hughes Lansing · Perrin C. White · Mary Murray
Impact of Body Weight Loss From Maximum Weight on Fragility Bone Fractures in Japanese Patients With type 2 Diabetes: the Fukuoka Diabetes Registry William H. Herman · Qing Pan · Sharon L. Edelstein · Kieren J. Mather · Leigh Perreault · Elizabeth Barrett-Connor · Dana Dabelea · Edward S. Horton · Steven E. Kahn · William C. Knowler · Carlos Lorenzo · Xavier Pi-Sunyer · Elizabeth M. Venditti · Wen Ye
First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes Melanie J. Davies · Melanie J. Davies · David A. D’Alessio · Judith E. Fradkin · Walter N. Kernan · Chantal Mathieu · Geltrude Mingrone · Geltrude Mingrone · Peter Rossing · Peter Rossing · Apostolos Tsapas · Deborah J. Wexler · John B. Buse
Transcription Factor 7-Like 2 (TCF7L2) Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes Steven V. Edelman · Nicholas B. Argento · Jeremy Pettus · Irl B. Hirsch
Use of a Metabolic Syndrome Severity Z Score to Track Risk During Treatment of Prediabetes: An Analysis of the Diabetes Prevention Program Sue A. Brown · Dan Raghinaru · Emma Emory · Boris P. Kovatchev
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials Hiroshi Itoh · Kenji Ueshima · Issei Komuro
Decreasing Cumulative Incidence of End-Stage Renal Disease in Young Patients With Type 1 Diabetes in Sweden: A 38-Year Prospective Nationwide Study Laura N. McEwen · Pearl G. Lee · Jye-Yu C. Backlund · Catherine L. Martin · William H. Herman
Maternal Antibiotic Use During Pregnancy and Type 1 Diabetes in Children—A National Prospective Cohort Study Cristina Razquin · Cristina Razquin · Estefanía Toledo · Estefanía Toledo · Clary B. Clish · Miguel Ruiz-Canela · Miguel Ruiz-Canela · Courtney Dennis · Dolores Corella · Dolores Corella · Christopher Papandreou · Christopher Papandreou · Emilio Ros · Emilio Ros · Ramón Estruch · Marta Guasch-Ferré · Marta Guasch-Ferré · Marta Guasch-Ferré · Enrique Gómez-Gracia · Enrique Gómez-Gracia · Montserrat Fitó · Edward Yu · José Lapetra · Dong D. Wang · Dora Romaguera · Liming Liang · Angel Alonso-Gómez · Amy Deik · Mònica Bulló · Mònica Bulló · Lluis Serra-Majem · Lluis Serra-Majem · Jordi Salas-Salvadó · Jordi Salas-Salvadó · Frank B. Hu · Frank B. Hu · Miguel Ángel Martínez-González
The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up Julie A. Lovshin · Julie A. Lovshin · Petter Bjornstad · Petter Bjornstad · Leif E. Lovblom · Johnny-Wei Bai · Yuliya Lytvyn · Genevieve Boulet · Mohammed A. Farooqi · Sam Santiago · Andrej Orszag · Daniel Scarr · Alanna Weisman · Hillary A. Keenan · Michael H. Brent · Narinder Paul · Vera Bril · Bruce A. Perkins · Bruce A. Perkins · David Z.I. Cherney
Impact of Visit-to-Visit Fasting Plasma Glucose Variability on the Development of Type 2 Diabetes: A Nationwide Population-Based Cohort Study Anny H. Xiang · Enrique Trigo · Mayra P. Martinez · Namir Katkhouda · Elizabeth Beale · Xinhui Wang · Jun Wu · Ting Chow · Cortney Montgomery · Krishna S. Nayak · Fadi Hendee · Thomas A. Buchanan
Adverse Childhood Experiences and the Risk of Diabetes: Examining the Roles of Depressive Symptoms and Cardiometabolic Dysregulations in the Whitehall II Cohort Study Jessica R. Castle
Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study Yiling J. Cheng · Giuseppina Imperatore · Linda S. Geiss · Sharon Saydah · Ann Albright · Mohammed K. Ali · Edward W. Gregg
Response to Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187–192 Brian L. Pearlman · Brian L. Pearlman · Brian L. Pearlman · Andrew Hinds · Alexandra-Elise Zakaud Dakaud
Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes Linda S. Geiss · Kai McKeever Bullard · Ralph Brinks · Edward W. Gregg
Executive Function Predicting Longitudinal Change in Type 1 Diabetes Management During the Transition to Emerging Adulthood Paul Muntner · Paul K. Whelton · Mark Woodward · Mark Woodward · Robert M. Carey
Is Mini-Dose Glucagon the Answer to Preventing Exercise-Related Dysglycemia? Tomas Vaisar · Blythe Durbin-Johnson · Kathryn B. Whitlock · Ilona Babenko · Rajnish Mehrotra · David M. Rocke · Maryam Afkarian
Trends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes, 1988–2015 Karine Goueslard · Jean-Michel Petit · Jonathan Cottenet · Jean-Christophe Chauvet-Gelinier · Fabrice Jollant · Fabrice Jollant · Catherine Quantin · Catherine Quantin
Considerations in Epidemiologic Definitions of Undiagnosed Diabetes Jincy Immanuel · David Simmons
A Comparison of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline and the 2017 American Diabetes Association Diabetes and Hypertension Position Statement for U.S. Adults With Diabetes Akihiro Tsuda · Eiji Ishimura · Hideki Uedono · Akinobu Ochi · Shinya Nakatani · Tomoaki Morioka · Katsuhito Mori · Junji Uchida · Masanori Emoto · Tatsuya Nakatani · Masaaki Inaba
Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy Muhammad Bayu Sasongko · Felicia Widyaputri · Dian Caturini Sulistyoningrum · Firman S. Wardhana · Tri Wahyu Widayanti · Supanji Supanji · Rifa Widyaningrum · Sarah R. Indrayanti · Idhayu A. Widhasari · Angela Nurini Agni
Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes Geremia B. Bolli
Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study Rasimcan Meral · Benjamin J. Ryan · Noemi Malandrino · Abdelwahab Jalal · Adam H. Neidert · Ranganath Muniyappa · Baris Akinci · Jeffrey F. Horowitz · Rebecca J. Brown · Elif A. Oral
A Perspective on the Accuracy of Blood Glucose Meters During Pregnancy Mary E. Lacy · Mary E. Lacy · Paola Gilsanz · Paola Gilsanz · Andrew J. Karter · Charles P. Quesenberry · Mark J. Pletcher · Rachel A. Whitmer · Rachel A. Whitmer · Rachel A. Whitmer
Association of Albuminuria With Intraglomerular Hydrostatic Pressure and Insulin Resistance in Subjects With Impaired Fasting Glucose or Impaired Glucose Tolerance Matthew C. Riddle · Rajaa Nahra · Jenny Han · Jessica R. Castle · Kathryn Hanavan · Marcus Hompesch · David Huffman · Poul Strange · Peter Öhman
John E. Gerich: Father of Modern Physiology of Glucose Homeostasis, Counterregulation to Hypoglycemia, and Mechanistic Treatment of Diabetes Joanna Klubo-Gwiezdzinska · Maria Lange · Elaine Cochran · Robert K. Semple · Cornelia Gewert · Rebecca J. Brown · Phillip Gorden
Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring Anna V. Mathew · Lei Li · Jaeman Byun · Yanhong Guo · George Michailidis · Mamta Jaiswal · Y. Eugene Chen · Rodica Pop-Busui · Subramaniam Pennathur
Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes Stine Møller Sildorf · Nina Breinegaard · Emilie Bundgaard Lindkvist · Janne Schurmann Tolstrup · Kirsten A. Boisen · Grete Teilmann · Anne Mette Skovgaard · Anne Mette Skovgaard · Jannet Svensson · Jannet Svensson
Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes Zhixi Li · Stuart Keel · Chi Liu · Yifan He · Wei Meng · Jane Scheetz · Pei Ying Lee · Jonathan E. Shaw · Daniel Ting · Tien Wong · Hugh R. Taylor · Robert T. Chang · Mingguang He · Mingguang He
Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial Drazenka Pongrac Barlovic · Valma Harjutsalo · Daniel Gordin · Milla Kallio · Carol Forsblom · Carol Forsblom · George L. King · Per-Henrik Groop
Poor Metabolic Control in Children and Adolescents With Type 1 Diabetes and Psychiatric Comorbidity Maria J. Redondo · Andrea K. Steck · Jay M. Sosenko · Mark S. Anderson · Peter A. Antinozzi · Aaron W. Michels · John M. Wentworth · Mark A. Atkinson · Alberto Pugliese · Susan Geyer
Hearing Impairment and Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort Mark D. DeBoer · Stephanie L. Filipp · Matthew J. Gurka
Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial in Type 1 Diabetes Complicated by Severe Hypoglycemia Emily J. Meyer · Emily J. Meyer · Genevieve M Gabb · Genevieve M Gabb · David Jesudason · David Jesudason
Childhood BMI and Adult Type 2 Diabetes, Coronary Artery Diseases, Chronic Kidney Disease, and Cardiometabolic Traits: A Mendelian Randomization Analysis Tomoyuki Kawada
Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype Barbara J. Anderson · Lori Laffel · Catherine Domenger · Thomas Danne · Moshe Phillip · Carmen Mazza · Ragnar Hanas · Sheridan Waldron · Roy W. Beck · Francoise Calvi-Gries · Chantal Mathieu
Fasting Glucose and All-Cause Mortality by Age in Diabetes: A Prospective Cohort Study Eberhard Standl · Susanna R. Stevens · Paul W. Armstrong · John B. Buse · Juliana C.N. Chan · Jennifer B. Green · John M. Lachin · André Scheen · Florence Travert · Frans Van de Werf · Eric D. Peterson · R R Holman
Markedly Decreasing Incidence of Blindness in People With and People Without Diabetes in Southern Germany Shylaja Srinivasan · Varinderpal Kaur · Bindu Chamarthi · Bindu Chamarthi · Katherine R. Littleton · Ling Chen · Alisa K. Manning · Alisa K. Manning · Jordi Merino · Melissa K. Thomas · Margo S. Hudson · Margo S. Hudson · Allison B. Goldfine · Allison B. Goldfine · Jose C. Florez · Jose C. Florez
Risk of Hypoglycemia After Hospital Discharge After Acute Kidney Injury in Patients With Diabetes Antonios Douros · Antonios Douros · Antonios Douros · Hui Yin · Oriana Hoi Yun Yu · Kristian B. Filion · Kristian B. Filion · Laurent Azoulay · Laurent Azoulay · Samy Suissa · Samy Suissa
Duration of diabetes and prediabetes during adulthood and subclinical atherosclerosis and cardiac dysfunction inmiddle age: The CARDIA study William L. Lowe · James R. Bain · Michael Nodzenski · Anna C. Reisetter · Michael J. Muehlbauer · Robert D. Stevens · Olga Ilkayeva · Lynn P. Lowe · Boyd E. Metzger · Christopher B. Newgard · Denise M. Scholtens
Excess Mortality in Patients With Type 1 Diabetes Without Albuminuria—Separating the Contribution of Early and Late Risks Spomenka Ljubić · Ivana Antal · Ana Jazbec · Martina Tomić · Ante Piljac · Lea. Smirčić-Duvnjak
BMI and Mortality in Patients With New-Onset Type 2 Diabetes: A Comparison With Age- and Sex-Matched Control Subjects From the General Population Heiner Claessen · Tatjana Kvitkina · Maria Narres · Christoph Trautner · Iris Zöllner · Bernd Bertram · Andrea Icks
Unstable Housing and Diabetes-Related Emergency Department Visits and Hospitalization: A Nationally Representative Study of Safety-Net Clinic Patients Iain M. Carey · Julia Critchley · Stephen DeWilde · Tess Harris · Fay J. Hosking
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4 Jared P. Reis · Norrina B. Allen · Michael P. Bancks · J. Jeffrey Carr · Cora E. Lewis · Joao A.C. Lima · Jamal S. Rana · Jamal S. Rana · Samuel S. Gidding · Pamela J. Schreiner
Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Yoriko Heianza · Dianjianyi Sun · Steven R. Smith · George A. Bray · Frank M. Sacks · Lu Qi · Lu Qi
Associations of General and Central Adiposity With Incident Diabetes in Chinese Men and Women Seth A. Berkowitz · Sara Kalkhoran · Samuel T. Edwards · Utibe R. Essien · Travis P. Baggett
Clinical Impact of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Uncontrolled Type 2 Diabetes and Very High Baseline HbA1c: The FREEDOM-1 HBL (High Baseline) Study Jean-Daniel Lalau · Farshad Kajbaf · Youssef Bennis · Anne-Sophie Hurtel-Lemaire · Frans M. Belpaire · Marc E. De Broe
Comment on Dubois-Laforgue et al. Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects. Diabetes Care 2017;40:1436-1443 Danièle Dubois-Laforgue · Danièle Dubois-Laforgue · Erika Cornu · Cécile Saint-Martin · Joël Coste · Christine Bellanné-Chantelot · J. Timsit
Comment on Han et al. Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans. Diabetes Care 2017;40:218–225 Sanjay Basu · Sanjay Basu · Sridharan Raghavan · Deborah J. Wexler · Seth A. Berkowitz
In an Anniversary Year, Diabetes Care Takes a Selfie Eiichi Araki · Shizuya Yamashita · Hidenori Arai · Koutaro Yokote · Jo Satoh · Toyoshi Inoguchi · Jiro Nakamura · Hiroshi Maegawa · Narihito Yoshioka · Yukio Tanizawa · Hirotaka Watada · Hideki Suganami · Shun Ishibashi
Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Robert R. Henry · Julio Rosenstock · Douglas S. Denham · Prakash Prabhakar · Lise Kjems · Michelle A. Baron
Response to Comment on Dubois-Laforgue et al. Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects. Diabetes Care 2017;40:1436–1443 Matthew C. Riddle
Erratum. Maternal BMI and Glycemia Impact the Fetal Metabolome. Diabetes Care 2017;40:902–910 Sanjay Kaul
Teasing Diabetes Apart, One Locus at a Time Alessandra M. Campos · Alessandra M. Campos · Andrei C. Sposito
Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany Ye-Xuan Cao · Jian-Jun Li
Insulin Detemir Use Is Associated With Higher Occurrence of Hypoglycemia in Hospitalized Patients With Hypoalbuminemia Xue Li · Xue Li · Xing Meng · Xiangchun Gao · Xiuyu Pang · Yanjiao Wang · Xiaoyan Wu · Xinrui Deng · Qiao Zhang · Changhao Sun · Ying Li
Comment on Burrows et al. Declining Rates of Hospitalization for Selected Cardiovascular Disease Conditions Among Adults Aged ≥35 Years With Diagnosed Diabetes, U.S., 1998–2014. Diabetes Care 2018;41:293–302 Eric Foster · Nancy D. Bridges · Irene D. Feurer · Thomas L. Eggerman · Lawrence G. Hunsicker · Rodolfo Alejandro
Comment on de Carvalho et al. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364–367 Nicole Oosterom · Christina M. Gant · Niels Ruiterkamp · Bert-Jan van Beijnum · Hermie J. Hermens · Stephan J. L. Bakker · Gerjan Navis · Miriam Marie Rosé Vollenbroek-Hutten · Gozewijn D. Laverman
The Presence of Diabetes and Higher HbA1c Are Independently Associated With Adverse Outcomes After Surgery Per-Henrik Groop · Merlin C. Thomas · Maija Feodoroff · Carol Forsblom · Valma Harjutsalo
Diabetes in Youth—Looking Backwards to Inform the Future: Kelly West Award Lecture 2017 Daniel Gordin · Valma Harjutsalo · Liane J. Tinsley · Ward Fickweiler · Jennifer K. Sun · Carol Forsblom · Peter S. Amenta · David M. Pober · Stephanie D’Eon · Maya Khatri · Isaac E. Stillman · Per-Henrik Groop · Hillary A. Keenan · George L. King
Current challenges and opportunities in the prevention and management of diabetic foot ulcers Irit Hochberg
Limb- and Person-Level Risk Factors for Lower-Limb Amputation in the Prospective Seattle Diabetic Foot Study Jose M. de Miguel-Yanes · Manuel Méndez-Bailón · Rodrigo Jiménez-García · Ana López-de-Andrés
TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH) Dorte Vistisen · Daniel R. Witte · Eric Brunner · Mika Kivimäki · Adam G. Tabak · Adam G. Tabak · Marit E. Jørgensen · Marit E. Jørgensen · Kristine Færch
Response to Comments on Santema et al. Hyperbaric Oxygen Therapy in the Treatment of Ischemic Lower-Extremity Ulcers in Patients With Diabetes: Results of the DAMO2CLES Multicenter Randomized Clinical Trial. Diabetes Care 2018;41:112–119 Dana Dabelea
Response to Comment on Ooi and Wong. Twin Pregnancy With Gestational Diabetes Mellitus: A Double Whammy? Diabetes Care 2018;41:e15–e16 William Jeffcoate · Loretta Vileikyte · Edward J. Boyko · David Armstrong · Andrew J.M. Boulton
American Diabetes Associations Standards of Care: A Paradigm Shift in the Dissemination of Information R. David Leslie · Struan F. A. Grant · Struan F. A. Grant
The Impact of Diabetes on Breast Cancer Treatments and Outcomes: A Population-Based Study Katharina Kähm · Michael Laxy · Udo Schneider · Wolf Rogowski · Stefan K. Lhachimi · Stefan K. Lhachimi · Rolf Holle
Risk of Cardiovascular Disease and Death in Individuals With Prediabetes Defined by Different Criteria: The Whitehall II Study Amélie Simoneau · Marie Monlun · Pauline Poupon · Laurence Baillet-Blanco · Laure Alexandre · Kamel Mohammedi · V. Rigalleau
Diagnosis and Significance of Pulmonary Microvascular Disease in Diabetes Katrien T.B. Santema · Robert M. Stoekenbroek · Mark J.W. Koelemay · Dirk T. Ubbink
Trends in Diabetes-Related Preventable Hospitalizations in the U.S., 2005–2014 Sara Ooi · Vincent W. Wong